Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03X OTHER ANTIANEMIC PREPARATIONS
B03XA Other antianemic preparations
B03XA05 Roxadustat
D10593 Roxadustat (JAN/USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D10593 Roxadustat (JAN/USAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D10593 Roxadustat
DG02924 UGT substrate
DG03188 UGT1A9 substrate
D10593 Roxadustat
Transporter substrate
DG01913 ABCG2 substrate
D10593 Roxadustat
DG02859 SLC22A6 substrate
D10593 Roxadustat
DG02860 SLC22A8 substrate
D10593 Roxadustat
DG02856 SLCO1B1 substrate
D10593 Roxadustat
Transporter inhibitor
DG02862 ABCG2 inhibitor
D10593 Roxadustat
DG02865 SLCO1B1 inhibitor
D10593 Roxadustat
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
HIF hydroxylase
EGLN (HPH)
D10593 Roxadustat (JAN/USAN/INN) <JP>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10593
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10593
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10593
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10593
Drug transporters
D10593